ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Storage: 2-8C
Application: Western Blotting Analysis: 1:1,000-1:10,000 from a representative lot detected Brn3a in mouse and rat brain tissue lysatesImmunocytochemistry Analysis: A 1:40 dilution from a representative lot detected Brn3a in Neuro2A cell line.Immunohistochemistry (Paraffin) Analysis: A 1:10,000 dilution from a representative lot detected Brn3a in human and mouse retina tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany